Mildronate® (Meldonium) is a cardioprotective drug for the adjuvant treatment of patients with mild chronic cardiac insufficiency which improves a clinical status, functional capacity, and quality of life.
Adjuvant treatment of mild chronic cardiac insufficiency.
Adults. The usual daily dose is 500-1000 mg of meldonium. The daily dose may be divided into two single doses. The maximum daily dose is 1000 mg. The treatment course varies from 4 to 6 weeks. For oral administration.
It is advised to use meldonium in the morning because of the possible stimulating effect. In order to avoid gastrointestinal disturbances, the medicinal product can be taken with food.
Mildronate ® in combination with traditional treatment chronic heart failure